Cognetivity Neurosciences (XCNQ:CGN) Change In Receivables : C$0.09 Mil (TTM As of Oct. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Change In Receivables?

Cognetivity Neurosciences's change in receivables for the quarter that ended in Oct. 2023 was C$0.02 Mil. It means Cognetivity Neurosciences's Accounts Receivable declined by C$0.02 Mil from Jul. 2023 to Oct. 2023 .

Cognetivity Neurosciences's change in receivables for the fiscal year that ended in Jan. 2023 was C$0.05 Mil. It means Cognetivity Neurosciences's Accounts Receivable declined by C$0.05 Mil from Jan. 2022 to Jan. 2023 .

Cognetivity Neurosciences's Accounts Receivable for the quarter that ended in Oct. 2023 was C$0.25 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Cognetivity Neurosciences's Days Sales Outstanding for the three months ended in Oct. 2023 was 792.93.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Cognetivity Neurosciences's liquidation value for the three months ended in Oct. 2023 was C$-15.48 Mil.

Cognetivity Neurosciences Change In Receivables Historical Data

The historical data trend for Cognetivity Neurosciences's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Change In Receivables Chart

Cognetivity Neurosciences Annual Data

Trend

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Change In Receivables

Get a 7-Day Free Trial

-0.08

0.15

-0.02

-0.15

0.05

Cognetivity Neurosciences Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Change In Receivables	Get a 7-Day Free Trial															-0.17	0.19	-	-0.12	0.02

Cognetivity Neurosciences Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.09 Mil.

Cognetivity Neurosciences (XCNQ:CGN) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Cognetivity Neurosciences's Days Sales Outstanding for the quarter that ended in Oct. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.252	/	0.029	*	91
=	792.93

2. In Ben Graham's calculation of liquidation value, Cognetivity Neurosciences's accounts receivable are only considered to be worth 75% of book value:

Cognetivity Neurosciences's liquidation value for the quarter that ended in Oct. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.017	-	15.682	+	0.75 * 0.252	+	0.5 * 0
=	-15.48

Cognetivity Neurosciences Change In Receivables Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Cognetivity Neurosciences (XCNQ:CGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (XCNQ:CGN) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

CGNSF:USA 1UB:Germany

Address

800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6

Website

https://www.cognetivity.com

Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (XCNQ:CGN) Headlines

No Headlines